Because glucagon receptor agonists are being developed to treat obesity (2-6), which is frequently complicated by MOSH (7), it is important to conclusively determine whether glucagon receptor agonism can directly modulate the reproductive axis in men. This evidence concerns the gene GCGR and obesity due to melanocortin 4 receptor deficiency.